Navigation Links
Many Nonprescription Cough Medicines Proves Ineffective

Experts say that much of the money spent on buying over-the-counter cough medicines is a waste adding that the active ingredients present in the so-called cough remedies may be ineffective. // It is stated that in US alone people spend around $3.5 billion a year to these nonprescription cough medicines.

There are many nonprescription cough medicines, but most contain the same types of active ingredients in a limited number of strengths and combinations.

Among them there are four types like:

Expectorants work by thinning mucus. Studies of their effectiveness vary, and the ACCP “cough committee” didn’t endorse them.

Suppressants work by dampening the cough reflex. They provide short-term relief for chronic bronchitis symptoms, but aren’t as effective on coughs caused by colds.

Decongestants work by constricting blood vessels, which shrinks swollen membranes and allows more air to pass through nasal passages. Decongestants can be effective in the short run, but they can cause side effects, and you can become dependent on decongestants in the form of nose drops.

Antihistamines help regardless of whether a cold or allergies is responsible for the cough.

So what should you take? The new guidelines advice leaving the cough and cold medicine section and buying an allergy medicine instead. Choose one that combines an older antihistamine (like brompheniramine, diphenhydramine, or chlorpheniramine) with a decongestant.

On the other hand, if you think a cold or cough medicine works, it probably won’t hurt you to stick with it, even if what you’re paying for is a placebo effect rather than a proven remedy, states the Harvard Health Letter.

Source: Newsise
'"/>




Page: 1

Related medicine news :

1. Cough Syrup Ingredient Linked to Stroke
2. Women Worse Affected By Chronic Cough
3. A Drug That Might Relieve Chronic Cough
4. Studying The Effectiveness Of Cough Syrups
5. Foods Rich In Flavonoids Effective In Prevention Of Cough
6. Cough medication to cure fibromyalgia
7. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
8. Rising Rates of Whooping Cough in Idaho
9. Cough Syrups No More Effective Than Sugar Water
10. Bariatric Surgery: Medicare, Will Now Cough Up For ‘Throwing Weight
11. Zimbabweans Will Need To Cough Up More on Health Costs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia ... 1, 2017. The name change aligns the entire company with its existing ... care quality. , “We are very proud of the achievements associated with the ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- KEY FINDINGS North America ... in 2016 and is expected to continue in the ... large number of surgical procedures that are taking place ... the patient temperature management market.) Patient warming and cooling ... blood during surgeries, lowering the risks of neurological disorders ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
(Date:12/8/2016)... 8 de dezembro de 2016  A Mederi Therapeutics Inc . anunciou ... tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto ... ... Live Stretta procedure performed and broadcast during the ... Wuhan Union Hospital ...
Breaking Medicine Technology: